Literature DB >> 28825055

National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference.

Ladan Afifi1,2, Lindsey Shankle3,2, April W Armstrong4,2, Marc Boas2, Alisha Bridges2, Vivian Chiguil1, Frank Doris2, Kristina Callis Duffin5, Eric Fielding1, Roy Fleischmann1, Joel M Gelfand6,2, Matthew Kiselica1, Catherine Kiselica1, Brian LaFoy1, John J Latella1, Junko Takeshita6,2, Sarah Truman2, Marilyn T Wan6,2, Vickie Wilkerson1, Jashin J Wu7,2, Michael P Siegel3,2, Wilson Liao1,2.   

Abstract

The National Psoriasis Foundation (NPF) is developing an agenda for patient-centered research to help patients and their caregivers make more informed health care decisions by engaging psoriasis patients in prioritizing comparative effectiveness research (CER) topics. The NPF has created a novel patient-centered research platform known as Citizen Pscientist (CP), allowing patients with psoriasis and psoriatic arthritis to register and contribute their health data. The CP Governance Council administered an online 23-question CER survey to the CP community and held a structured meeting on December 3, 2016, with patients and researchers to review CER survey results and discuss patient-centered research priorities. Of the 2,945 patients surveyed, 792 patients responded. Three CER topics were deemed to be of high priority for the research agenda: 1) Treat-to-target therapy for psoriasis, 2) Psoriatic arthritis screening questionnaires for early detection and treatment of psoriatic arthritis, and 3) Comparative effectiveness of home-based phototherapy for psoriasis.

Entities:  

Keywords:  Citizen Pscientist; comparative effectiveness research; home phototherapy; patient-centered research; psoriasis; psoriatic arthritis; screening questionnaire; treat-to-target

Year:  2017        PMID: 28825055      PMCID: PMC5562437          DOI: 10.1177/247553031700200307

Source DB:  PubMed          Journal:  J Psoriasis Psoriatic Arthritis        ISSN: 2475-5303


  30 in total

1.  Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.

Authors:  Junko Takeshita; Kristina Callis Duffin; Daniel B Shin; Gerald G Krueger; Andrew D Robertson; Andrea B Troxel; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2014-06-11       Impact factor: 11.527

2.  Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis.

Authors:  Joy Wan; Katrina Abuabara; Andrea B Troxel; Daniel B Shin; Abby S Van Voorhees; Bruce F Bebo; Gerald G Krueger; Kristina Callis Duffin; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2012-04

3.  Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.

Authors:  Joel M Gelfand; Joy Wan; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Michael B Stierstorfer; Bruce A Brod; Stephen M Schleicher; Bruce F Bebo; Andrea B Troxel; Daniel B Shin; Jane M Steinemann; Jennifer Goldfarb; Howa Yeung; Abby S Van Voorhees
Journal:  Arch Dermatol       Date:  2012-04

4.  Are narrow-band ultraviolet B home units a viable option for continuous or maintenance therapy of photoresponsive diseases?

Authors:  Kay-Anne Haykal; Jean-Pierre DesGroseilliers
Journal:  J Cutan Med Surg       Date:  2006 Sep-Oct       Impact factor: 2.092

5.  Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis.

Authors:  Muhammad Haroon; Phil Gallagher; Oliver FitzGerald
Journal:  Ann Rheum Dis       Date:  2014-02-13       Impact factor: 19.103

6.  Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.

Authors:  Katrina Abuabara; Joy Wan; Andrea B Troxel; Daniel B Shin; Abby S Van Voorhees; Bruce F Bebo; Gerald G Krueger; Kristina Callis Duffin; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2012-08-19       Impact factor: 11.527

7.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 8.  2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol.

Authors:  Sidney C Smith; Scott M Grundy
Journal:  J Am Coll Cardiol       Date:  2014-08-12       Impact factor: 24.094

9.  Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice.

Authors:  K Callis Duffin; H Yeung; J Takeshita; G G Krueger; A D Robertson; A B Troxel; D B Shin; A S Van Voorhees; J M Gelfand
Journal:  Br J Dermatol       Date:  2014-03       Impact factor: 9.302

10.  Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).

Authors:  Mayke B G Koek; Erik Buskens; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Vigfús Sigurdsson
Journal:  BMJ       Date:  2009-05-07
View more
  3 in total

1.  Engaging the Patient's Perspective in Clinical Trials Research.

Authors:  Brooke Hefele; Sinéad M Langan; Karen Pollins; Joel M Gelfand
Journal:  J Invest Dermatol       Date:  2019-03-14       Impact factor: 8.551

2.  Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice.

Authors:  Savannah D Neu; Anna Strzepa; Dustin Martin; Mary G Sorci-Thomas; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Antioxidants (Basel)       Date:  2021-08-25

3.  Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts.

Authors:  Isabelle M Sanchez; Lindsey Shankle; Marilyn T Wan; Ladan Afifi; Jashin J Wu; Frank Doris; Alisha Bridges; Marc Boas; Brian Lafoy; Sarah Truman; Ana-Maria Orbai; Junko Takeshita; Joel M Gelfand; April W Armstrong; Michael P Siegel; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2018-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.